About JDRF Clinical Trials
JDRF Canadian Clinical Trial Network (JDRF CCTN) is an initiative to accelerate solutions for the management, care, and cure of type 1 diabetes (T1D)
CCTN creates a strong clinical research network to develop and conduct leading-edge clinical trials in T1D and its complications, in order to accelerate delivery of the benefits of research advances to the community. At present, the initiative includes over 20 networked institutions acting as CCTN clinical research partners. CCTN sites collaborate to run multi-site clinical trials within Canada, and also with international partners in the US, UK, Europe and Australia. Created in partnership with the Government of Canada, funding for JDRF CCTN came from a commitment of $20 million by the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), with an additional $14 million contribution from JDRF. The $34 million investment is accelerating the testing of new technologies and treatments for Canadians and individuals around the world living with T1D and its complications.
Through the generous $3 million investment from the WB Family Foundation, JDRF CCTN is expanding to western Canada. JDRF is committed to continue the growth and expansion of the CCTN to bring ground-breaking innovation and research to all Canadians living with T1D.
The video below provides an overview of JDRF CCTN as well as takes a closer look into the life of a family faced with T1D.